Adriana B. Morelli

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The anti-interleukin-6 antibody ALD518-P18 mitigates murine kidney ischemia-reperfusion injury.

The anti-interleukin-6 antibody ALD518-P18 mitigates murine kidney ischemia-reperfusion injury.

Journal: Scientific reports

Published: October 09, 2025

Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy.

Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy.

Journal: Journal of inflammation (London, England)

Published: August 12, 2024

A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injury.

A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injury.

Journal: Scientific reports

Published: July 15, 2021

Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.

Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.

Journal: Neuropharmacology

Published: October 25, 2017

A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.

A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.

Journal: NPJ vaccines

Published: August 16, 2016

Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.

Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 11, 2014

Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine.

Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine.

Journal: Human vaccines & immunotherapeutics

Published: February 12, 2014

Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine.

Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine.

Journal: Vaccine

Published: November 21, 2013

Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events.

Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events.

Journal: Vaccine

Published: November 21, 2013

Combination of adjuvants: the future of vaccine design.

Combination of adjuvants: the future of vaccine design.

Journal: Expert review of vaccines

Published: July 27, 2013

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.

Journal: Vaccine

Published: January 25, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026